Showing results (391-400 of 7,002) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|June 9, 2020
Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lungTomohito Saito, Koji Tsuta, Osamu Honda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2020
Clinical outcomes and the role of bronchoscopic intervention in patients with primary pulmonary salivary gland-type tumorsBo-Guen Kim, Kyungjong Lee, Sang-Won Um, et al.
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Ophthalmological assessment of crizotinib in advanced non-small-cell lung cancerBenjamin J Solomon, Elizabeth E Kim, Maria Winter, et al.
Lung Cancer (Amsterdam, Netherlands)|May 28, 2020
Circulating tumor DNA analysis of EGFR-mutant non-small cell lung cancer patients receiving osimertinib following previous tyrosine kinase inhibitor treatmentJamie J Beagan, Sander Bach, Robert A van Boerdonk, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2020
Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patientsAki K Kobayashi, Hidehito Horinouchi, Yuko Nakayama, et al.
Lung Cancer (Amsterdam, Netherlands)|June 10, 2020
Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference CenterGiulia Galli, Annalisa Trama, Laura Abate-Daga, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cellsKenji Otsuka, Atsushi Mitsuhashi, Hisatsugu Goto, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2020
NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migrationYuki Ikematsu, Kentaro Tanaka, Goji Toyokawa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2020
Lung adenocarcinoma with a novel SRBD1-ALK Fusion responding to crizotinibYao Chen, Xiaochen Zhang, Qi Jiang, et al.
Pageof 701